LEADERSHIP INSIGHTS

Criticaleye's Leadership Insight newsletter is read bi-weekly by leaders across our Community.



Choose your timeframe and then click on any of the topics below to see the corresponding newsletter. If you would like to comment further on any of these topics, write to us via info@criticaleye.com.




Should NEDs be Paid More?

As the extra responsibility, time commitment and reputational risk continues to reshape the role of a non-executive director, one may question whether it’s time to change how NEDs are remunerated. Should pay be more reflective of the greater workload, or could this lead to a conflict of interest? [read more]

Where do CEOs Turn for Help?

Fractious board dynamics, disgruntled shareholders and poor performance will put enormous pressure on a CEO, especially if they’re new to the role. While solutions may not be easy to come by, it can be difficult for a leader to openly admit they don’t have the answers. That’s where a mentor can make a big difference. [read more]

Responsible Leadership

Corporates continue to spawn mistrust, and while shortfalls and scandals aren’t new, the reaction to them is. The internet and media play a big part – a story can break at speed, damaging both reputation and profit. As such, CEOs and senior executives are expected to lead in a transparent and responsible way. [read more]

The First 72 Hours in a Turnaround

A company in crisis is like a ship with no sails. If tasked with navigating through a turnaround, it’ll take swift, decisive action to steer the company straight. Furthermore, you’ll need good communication with investors, suppliers and other stakeholders in order to chart a course to a secure future. [read more]











Tullow Oil plc Google Redwood Bank NATS Eton Bridge Partners Bunzl plc LDC Eightfold AI London Stock Exchange Concentrix Veolia Water Technologies Amazon UK Drax Group plc Royal London Group Lightsource bp Mayborn Group Salesforce E.ON UK Workday Accenture Legal & General Investment Management AlixPartners Robert Walters GlaxoSmithKline plc